USA. DEA Announces Proposed Rules for Permanent Telemedicine Flexibilities
USA. DEA Announces Proposed Rules for Permanent Telemedicine Flexibilities
DEA extends many telemedicine flexibilities adopted during the COVID-19 PHE with appropriate safeguards
WASHINGTON - Today, the Drug Enforcement Administration announced proposed permanent rules for the prescribing of controlled medications via telemedicine, expanding patient access to critical therapies beyond the scheduled end of the COVID-19 public health emergency. The public will be able to comment for 30 days on the proposed rules.
The proposed rules – developed with the U.S. Department of Health and Human Services and in close coordination with the U.S. Department of Veterans Affairs – propose to extend many of the flexibilities adopted during the public health emergency with appropriate safeguards. (DEA - Drug Enforcement Administration, USA, 24.02.2023)
https://www.dea.gov/press-releases/2023/02/24/dea-announces-proposed-rules-permanent-telemedicine-flexibilities